Authors: Yu-Qiang Lu ,Hui Ding ,Zhao-Lin Shi ,Hai-Bo Lin ,Guo-Cheng Zhang, ＊

1Shaanxi University of Chinese Medicine,Xianyang 712046,China.

2Children's Hospital,The Second Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712046,China.

Drug Combination Therapyhas retracted this article because the data is falsified,the core targets are wrong and this English article has a high repetition rate compared with a Chinese article.

Drug Combination Therapyreceived the author’s manuscript on 13 April 2022.After the plagiarism check on 13 April 2022,the similarity rate of this article was 15% (Supplementary 1),which was qualified.Then the manuscript was started to be sent for peer-review at 10:10 on 19 April 2022.This manuscript was sent to eight reviewers and three of them sent back the comments.Two of these reviewers were invited to peer-review on 21 April 2022 and the other was invited on 24 April 2022.Due to the journal’s single-blind peer-review policy,we do not give the names of the three reviewers here.One reviewer gave the decision “Reject in current form,but may be resubmitted”,one reviewer gave the decision “Accepted subject to revision,as noted in comments” and the other reviewer gave the decision “Accept with minor changes”.

When the comments from the reviewers were received,the authors were informed about revising the manuscript according to the comments on 24 April 2022.They sent back the final revised version of this manuscript on 27 April 2022.This manuscript was accepted on 27 April 2022.After typesetting,this manuscript was online on 30 April 2022.

On 27 June 2022,the first author Yu-Qiang Lu sent an email to ask to withdraw the article.The reasons include: 1.The data is falsified,and the core targets are wrong.All pictures and content in the article are based on the core targets,which means that as long as one target changes,all the figures and data have to change.Therefore,the figures and data of the whole article are not real.The reason is that the target frequency was manually entered,and the wrong core targets were obtained (Supplementary 2);2.This English article has a high repetition rate compared with a Chinese article: Zhang L,Zhao F,Liu ZZ,et al.Study on the mechanism of Cymbidium-Xanthium in the treatment of allergic rhinitis based on network pharmacology.Journal of Shaanxi College of Traditional Chinese Medicine,2021,44(06):73–83.DOI:10.13424/j.cnki.jsctcm.2021.06.016(張璐,趙菲,劉珍珍,等.基于網(wǎng)絡(luò)藥理學(xué)的辛夷-蒼耳子藥對治療變應(yīng)性鼻炎作用機制探討[J].陜西中醫(yī)藥大學(xué)學(xué)報,2021,44(06):73-83.DOI:10.13424/j.cnki.jsctcm.2021.06.016).

According to COPE (Editors should consider retracting a publication if: They have clear evidence that the findings are unreliable,either as a result of major error (eg,miscalculation or experimental error),or as a result of fabrication (eg,of data) or falsification (eg,image manipulation)),the editor-in-chief ofDrug Combination Therapyagreed to the retraction of this article.

Supplementary materials can be found on: https://www.tmrjournals.com/article.html?J_num=6&a_id=2225